Lynne M. Ball

4.4k total citations · 1 hit paper
37 papers, 3.3k citations indexed

About

Lynne M. Ball is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Lynne M. Ball has authored 37 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 14 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Lynne M. Ball's work include Hematopoietic Stem Cell Transplantation (19 papers), Mesenchymal stem cell research (14 papers) and Neonatal Respiratory Health Research (4 papers). Lynne M. Ball is often cited by papers focused on Hematopoietic Stem Cell Transplantation (19 papers), Mesenchymal stem cell research (14 papers) and Neonatal Respiratory Health Research (4 papers). Lynne M. Ball collaborates with scholars based in Netherlands, Canada and Sweden. Lynne M. Ball's co-authors include Helene Roelofs, Franco Locatelli, Willem E. Fibbe, Maria Ester Bernardo, R. Maarten Egeler, Olle Ringdén, Katarina Le Blanc, Berit Sundberg, Francesco Frassoni and Giorgio Dini and has published in prestigious journals such as The Lancet, Blood and Cancer.

In The Last Decade

Lynne M. Ball

36 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

2008 2.0k citations Katarina Le Blanc, Francesco Frassoni et al. The Lancet profile →

Peers

Countries citing papers authored by Lynne M. Ball

Since Specialization

Citations

This map shows the geographic impact of Lynne M. Ball's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynne M. Ball with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynne M. Ball more than expected).

Fields of papers citing papers by Lynne M. Ball

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynne M. Ball. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynne M. Ball. The network helps show where Lynne M. Ball may publish in the future.

Co-authorship network of co-authors of Lynne M. Ball

This figure shows the co-authorship network connecting the top 25 collaborators of Lynne M. Ball. A scholar is included among the top collaborators of Lynne M. Ball based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynne M. Ball. Lynne M. Ball is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk-adapted approach for fever and neutropenia in paediatric cancer patients – A national multicentre study 2015 ·European Journal of Cancer ·Karin G. E. Miedema, Wim J. E. Tissing, Floor Abbink, Lynne M. Ball, Erna Michiels, Michel J. van Vliet, (unknown), Willem A. Kamps, Obbe F. Norbruis, Marta Fiocco, Hester A. de Groot‐Kruseman, Marianne D. van de Wetering, Eveline S.J.M. de Bont	39
2	Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells 2015 ·Cancer Immunology Immunotherapy ·(unknown), Monique M. van Ostaijen-ten Dam, Kathelijne C.J.M. Kraal, Susy J. Santos, Lynne M. Ball, Arjan C. Lankester, Marco W. Schilham, R. Maarten Egeler, Maarten J. D. van Tol	23
3	Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association 2015 ·Biology of Blood and Marrow Transplantation ·Menachem Bitan, Suzanna M. van Walraven, Nina Worel, Lynne M. Ball, Jan Styczyński, Marta Torrabadella, Volker Witt, Bronwen E. Shaw, Adriana Seber, Hiromasa Yabe, Hildegard Greinix, Christina Peters, Éliane Gluckman, Vanderson Rocha, Joerg Halter, Michael A. Pulsipher	11
4	The Effect of Cidofovir on Adenovirus Plasma DNA Levels in Stem Cell Transplantation Recipients without T Cell Reconstitution 2014 ·Biology of Blood and Marrow Transplantation ·Gertjan Lugthart, (unknown), Cornelia M. Jol‐van der Zijde, Lynne M. Ball, Dorine Bresters, Wouter J.W. Kollen, Frans J. Smiers, Clementien L. Vermont, Robbert G. M. Bredius, Marco W. Schilham, Maarten J. D. van Tol, Arjan C. Lankester	30
5	Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses 2013 ·Cytotherapy ·Friso Calkoen, D. M. C. Brinkman, (unknown), Monique M. van Ostaijen-ten Dam, R. ten Cate, Maarten J. D. van Tol, Lynne M. Ball	19
6	Gastrointestinal Acute Graft-versus-Host Disease in Children: Histology for Diagnosis, Mesenchymal Stromal Cells for Treatment, and Biomarkers for Prediction of Response 2013 ·Biology of Blood and Marrow Transplantation ·Friso Calkoen, Cornelia M. Jol‐van der Zijde, M. Luisa Mearin, Joachim J. Schweizer, Anja M. Jansen-Hoogendijk, Helene Roelofs, Astrid G. S. van Halteren, R. Maarten Egeler, Maarten J. D. van Tol, Lynne M. Ball	12
7	Nonpharmacologic Treatment of Chronic Graft-versus-Host Disease in Children and Adolescents 2012 ·Biology of Blood and Marrow Transplantation ·Ánita Lawitschka, Lynne M. Ball, Christina Peters	17
8	Immunotherapy in the Context of Hematopoietic Stem Cell Transplantation: The Emerging Role of Natural Killer Cells and Mesenchymal Stromal Cells 2010 ·Pediatric Clinics of North America ·Arjan C. Lankester, Lynne M. Ball, Peter Lang, Rupert Handgretinger	5
9	Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study breakdown → 2008 ·The Lancet ·Katarina Le Blanc, Francesco Frassoni, Lynne M. Ball, Franco Locatelli, Helene Roelofs, Ian A. Lewis, Edoardo Lanino, Berit Sundberg, Maria Ester Bernardo, Mats Remberger, Giorgio Dini, R. Maarten Egeler, Andrea Bacigalupo, Willem E. Fibbe, Olle Ringdén	2038
10	Granulocyte transfusion in paediatric haemato-oncology and haematopoietic stem cell transplantation 2007 ·Reports of Practical Oncology & Radiotherapy ·Lynne M. Ball	1
11	Intensive care and outcome in children undergoing haematopoietic stem cell transplantation 2007 ·Reports of Practical Oncology & Radiotherapy ·Lynne M. Ball	6
12	Diabetes insipidus in a child with a monosomy‐7 associated myelodysplastic syndrome and neurofibromatosis I 2003 ·Medical and Pediatric Oncology ·Wouter J.W. Kollen, Lynne M. Ball, (unknown), Shama L. van Zelderen‐Bhola, R. Maarten Egeler	5
13	Pharmacokinetics of intravenous busulfan in children prior to stem cell transplantation 2002 ·British Journal of Clinical Pharmacology ·Serge Cremers, Rik C. Schoemaker, Robbert G. M. Bredius, Jan den Hartigh, Lynne M. Ball, Irene M. Twiss, Pieter Vermeij, Jaak M. Vossen	46
14	Proliferation and Apoptosis Does Not Affect Presenting White Cell Count in Childhood All 1999 ·Advances in experimental medicine and biology ·(unknown), Lynne M. Ball, (unknown), (unknown), (unknown), D. Christie Riddell, Dick van Velzen	2
15	Microsatellite Instability Assessment in Prediction of Drug Resistance in Childhood Burkitt’s and Large Cell Diffuse Malignant Non-Hodgkin Lymphoma (MNHL) 1999 ·Advances in experimental medicine and biology ·(unknown), (unknown), Lynne M. Ball, (unknown), (unknown), Dick van Velzen	2
16	Differential Kinetics of Drug Resistance in Human Leukaemic Cells Measured by SCGE/CLSM 1999 ·Advances in experimental medicine and biology ·Lynne M. Ball, (unknown), G. R. Langley, (unknown), (unknown), Dick van Velzen	1
17	PCNA Bearing Structures are Retained in Apoptotic Phase of Childhood All Cell Cycle 1999 ·Advances in experimental medicine and biology ·Lynne M. Ball, (unknown), (unknown), (unknown), (unknown), (unknown), D. Christie Riddell, Dick van Velzen	3
18	Apoptosis Corrected Proliferation Fraction in Childhood All is Related to Karyotype 1999 ·Advances in experimental medicine and biology ·Lynne M. Ball, (unknown), (unknown), (unknown), (unknown), (unknown), D. Christie Riddell, Dick van Velzen	1
19	PCNA Ki‐67 dissociation in childhood acute lymphoblastic leukaemia. An Immunofluorescent Laser Confocal Scanning Microscopical study. 1994 ·Cell Biology International ·Lynne M. Ball, (unknown), C. V. Howard, (unknown), Dick van Velzen	4
20	The use of DNA probes to monitor minimal residual disease in childhood acute lymphoblastic leukaemia 1989 ·British Journal of Haematology ·F Katz, Lynne M. Ball, Barbara Gibbons, Judith M. Chessells	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact